首页 › 基金 › Rosalind Advisors, Inc. › GRCE
Rosalind Advisors, Inc. 对 GRCE 的持仓历史
GRACE THERAPEUTICS INC · 医疗保健
Rosalind Advisors, Inc. 在 Q3 2026 的 13F 申报中披露持有 GRCE(GRACE THERAPEUTICS INC)476,190 股,市值约 US$1.0M,约占其申报组合的 0.42%,在其申报持仓中市值排名第 29 位。 Rosalind Advisors, Inc. 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Rosalind Advisors, Inc. 对 GRCE 的持仓演变
Rosalind Advisors, Inc. 于 Q3 2026 首次披露 GRCE 持仓:476,190 股(约 US$1.0M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 476.19K | $1.02M | 新进 |
关于 GRCE 与 13F 数据
GRCE(GRACE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 35 只申报持有 GRCE。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Rosalind Advisors, Inc.
常见问题
How long has Rosalind Advisors, Inc. held GRCE?
Rosalind Advisors, Inc. has disclosed GRCE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Rosalind Advisors, Inc.'s current position in GRCE?
As of Q3 2026, Rosalind Advisors, Inc. holds 476.19K shares of GRCE (GRACE THERAPEUTICS INC), valued at $1.02M, representing 0.42% of its reported portfolio and ranking #29.
Has Rosalind Advisors, Inc. been buying or selling GRCE?
In the latest 13F filing (Q3 2026), Rosalind Advisors, Inc. newly opened its position in GRCE.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.